Deanna L. Kirkpatrick

Davis Polk advised DXC Technology Company in connection with its registered exchange offers of (i) up to $445.265 million aggregate principal amount of DXC’s new 4.45% senior notes due 2022…

Davis Polk advised the dealer manager on Ciena Corporation’s offer to exchange up to $350 million aggregate principal amount at maturity of outstanding 3.75% convertible senior notes…

Davis Polk advised the underwriters in connection with the SEC-registered offering of $1.5 billion aggregate principal amount of 2.200% bonds due July 26, 2022, issued by the Province…

Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public offering of common stock of Kala Pharmaceuticals, Inc. The…

Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on…

Davis Polk advised the underwriters in connection with the offering of $500 million aggregate principal amount of 1.625% U.S. dollar bonds due 2020 issued by Export Development Canada. The…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 2.250% bonds due May 18, 2022, issued by the Province of Ontario. The Davis…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 2.000% U.S. dollar bonds due 2022 issued by Export Development Canada…

Davis Polk advised the joint lead dealer managers in connection with the registered offers by Abbott Laboratories to exchange certain outstanding debt securities of St. Jude Medical,…

Davis Polk advised the sole sales agent in connection with an SEC-registered at-the-market offering by Tellurian Inc. of its shares of common stock having an aggregate offering price of up…